Journal: Nat Commun
Publication Date: 2025-09-29
DOI: 10.1038/s41467-025-63554-4
NIH Citation: Xu P, Xi Y, Kim JW, Zhang M, Gao C, Wang Y, Xu M, Wang X, Ren S, Yang D, Wang Q, Xie W. A loss-of-function human ADAR variant activates innate immune response and promotes bowel inflammation. Nat Commun. 2025;16(1):8560. PMCID: PMC12480066.
PubMed PMID: 41022715
Journal: Nat Rev Clin Oncol
Publication Date: 2025-09-01
DOI: 10.1038/s41571-025-01040-y
NIH Citation: Carleton N, McAuliffe PF. Overdiagnosis, competing morbidity and tumour biology in older women with breast cancer: building a case for active monitoring. Nat Rev Clin Oncol. 2025;.
PubMed PMID: 40490477
Journal: JAMA Surg
Publication Date: 2025-07-01
DOI: 10.1001/jamasurg.2025.1072
NIH Citation: Basik M, Cecchini RS, De Los Santos JF, Umphrey HR, Julian TB, Mamounas EP, White JR, Lucas PC, Balanoff CR, Tan AR, Weber JJ, Edmonson DA, Brown-Glaberman UA, Diego EJ, Teshome M, Matsen CB, Seaward SA, Wapnir IL, Wagner JL, Tjoe JA, Thompson AM, Wolmark N. Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical Trial. JAMA Surg. 2025;. PMCID: PMC12060017.
PubMed PMID: 40332918
Journal: Lancet
Publication Date: 2025-06-21
DOI: 10.1016/S0140-6736(25)01040-2
NIH Citation: Olawaiye AB, Gladieff L, O'Malley DM, Kim JW, Garbaos G, Salutari V, Gilbert L, Mileshkin L, Devaux A, Hopp E, Lee YJ, Oaknin A, Scaranti M, Kim BG, Colombo N, McCollum ME, Diakos C, Clamp A, Leiser AL, Balázs B, Monk BJ, Scandurra G, McClung E, Kaczmarek E, Slomovitz B, De La Cueva H, de Carvalho Calabrich AF, Cassani C, You B, Van Gorp T, Churruca C, Caruso G, Nicum S, Bagaméri A, Artioli G, Bodnar L, Kang S, Vergote I, Kesner-Hays A, Pashova HI, Pai SG, Tudor IC, Jubb AM, Lorusso D. Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial. Lancet. 2025;.
PubMed PMID: 40473448
Journal: J Natl Compr Canc Netw
Publication Date: 2025-06-11
DOI: 10.6004/jnccn.2025.7013
NIH Citation: Ellsworth SG, Abdelhakiem M, Elgohari B, Mohammed M, Shogan J, Vera A, Burton SA, Olson AC, Lee KKW, Paniccia A, Zhang JY, Lotze MT, Zureikat AH. Lessons Learned About Acute and Late Toxicity After Two Decades of Experience With Pancreatic SBRT. J Natl Compr Canc Netw. 2025;:1-6.
PubMed PMID: 40505682
Journal: N Engl J Med
Publication Date: 2025-06-05
DOI: 10.1056/NEJMoa2414859
NIH Citation: Mamounas EP, Bandos H, White JR, Julian TB, Khan AJ, Shaitelman SF, Torres MA, Vicini FA, Ganz PA, McCloskey SA, Lucas PC, Gupta N, Li XA, McCormick B, Smith B, Tendulkar RD, Kavadi VS, Matsumoto K, Seaward SA, Irvin WJ Jr, Lin JY, Mutter RW, Muanza TM, Stromberg J, Jagsi R, Weiss AC, Curran WJ Jr, Wolmark N. Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy. N Engl J Med. 2025;392(21):2113-2124. PMCID: PMC12269788.
PubMed PMID: 40466065
Journal: Pharmacol Res
Publication Date: 2025-06-01
DOI: 10.1016/j.phrs.2025.107779
NIH Citation: Feng Y, Kim JW, Xie W. The intestinal functions of PXR and CAR. Pharmacol Res. 2025;:107779.
PubMed PMID: 40378938
Journal: Nat Commun
Publication Date: 2025-05-05
DOI: 10.1038/s41467-025-59490-y
NIH Citation: Huang H, Mu Y, Huang Y, Ji B, Wang Y, Chen CY, Chen Y, Luo Z, Li S, Zhang Z, Wang L, Conway JF, Yang D, Wang J, Sun J, Li S. Rational development of gemcitabine-based nanoplatform for targeting SERPINB9/Granzyme B axis to overcome chemo-immune-resistance. Nat Commun. 2025;16(1):4176. PMCID: PMC12053578.
PubMed PMID: 40325025
Journal: Pharmacol Rev
Publication Date: 2025-05-01
DOI: 10.1016/j.pharmr.2025.100045
NIH Citation: Kim JW, Tung HC, Yang B, Pant R, Guan X, Feng Y, Xie W. Heme-thiolate monooxygenase cytochrome P450 1B1, an old dog with many new tricks. Pharmacol Rev. 2025;77(3):100045.
PubMed PMID: 40054133
Journal: Chem Rev
Publication Date: 2025-02-26
DOI: 10.1021/acs.chemrev.4c00224
NIH Citation: Charette M, Rosenblum C, Shade O, Deiters A. Optogenetics with Atomic Precision─A Comprehensive Review of Optical Control of Protein Function through Genetic Code Expansion. Chem Rev. 2025;. PMCID: PMC11869211.
PubMed PMID: 39928721
Journal: Adv Funct Mater
Publication Date: 2025-02-12
DOI: 10.1002/adfm.202411334
NIH Citation: Huang H, Ji B, Huang Y, Li S, Luo Z, Chen S, Li S, Chen Y, Bain DJ, Sun J, Yang D, Burns TF, Wang J, Li S. Advanced hierarchical computational modeling-based rational development of platinum (II) nanocomplex to improve lung cancer therapy. Adv Funct Mater. 2025;35(7). PMCID: PMC12124824.
PubMed PMID: 40452781
Journal: N Engl J Med
Publication Date: 2025-01-16
DOI: 10.1056/NEJMoa2406070
NIH Citation: Geyer CE Jr, Untch M, Huang CS, Mano MS, Mamounas EP, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, D'Hondt V, Conlin AK, Guarneri V, Wapnir IL, Jackisch C, Arce-Salinas C, Fasching PA, DiGiovanna MP, Crown JP, Wuelfing P, Shao Z, Rota Caremoli E, Bonnefoi HR, Hennessy BT, Stamatovic L, Castro-Salguero H, Brufsky AM, Knott A, Siddiqui A, Lambertini C, Boulet T, Nyawira B, Restuccia E, Loibl S, KATHERINE Study Group. Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer. N Engl J Med. 2025;392(3):249-257.
PubMed PMID: 39813643
Journal: Cancer Lett
Publication Date: 2024-12-03
DOI: 10.1016/j.canlet.2024.217362
NIH Citation: Tojjari A, Idrissi YA, Saeed A. Emerging targets in gastric and pancreatic cancer: Focus on Claudin 18.2. Cancer Lett. 2024;:217362.
PubMed PMID: 39637967
Journal: Cancer Lett
Publication Date: 2024-11-01
DOI: 10.1016/j.canlet.2024.217268
NIH Citation: Luo Z, Huang Y, Chen S, Zhang B, Huang H, Dabiri S, Chen Y, Zhang A, Andreas AR, Li S. Delivery of PARP inhibitors through 2HG-incorporated liposomes for synergistically targeting DNA repair in cancer. Cancer Lett. 2024;:217268.
PubMed PMID: 39321912
Journal: J Clin Oncol
Publication Date: 2024-10-20
DOI: 10.1200/JCO.23.01995
NIH Citation: Rastogi P, Bandos H, Lucas PC, van 't Veer LJ, Wei JJ, Geyer CE Jr, Fehrenbacher L, Chia SKL, Brufsky AM, Walshe JM, Soori GS, Dakhil SR, Paik S, Swain SM, Menicucci AR, Audeh MW, Wolmark N, Mamounas EP. Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial. J Clin Oncol. 2024;:JCO2301995. PMCID: PMC11469649.
PubMed PMID: 39047219
Journal: JAMA Surg
Publication Date: 2024-10-01
DOI: 10.1001/jamasurg.2024.2407
NIH Citation: Carleton N, Radomski TR, Li D, Zou J, Harris J, Hamm M, Wang Z, Saadawi G, Fischer GS, Arnold J, Cowher MS, Lupinacci K, Sabih Q, Steiman J, Johnson RR, Soran A, Diego EJ, Oesterreich S, Tseng G, Lee AV, McAuliffe PF. Electronic Health Record-Based Nudge Intervention and Axillary Surgery in Older Women With Breast Cancer: A Nonrandomized Controlled Trial. JAMA Surg. 2024;. PMCID: PMC11255976.
PubMed PMID: 39018053
Journal: Sci Transl Med
Publication Date: 2024-09-25
DOI: 10.1126/scitranslmed.adk8446
NIH Citation: Tung HC, Kim JW, Zhu J, Li S, Yan J, Liu Q, Koo I, Koshkin SA, Hao F, Zhong G, Xu M, Wang Z, Wang J, Huang Y, Xi Y, Cai X, Xu P, Ren S, Higashiyama T, Gonzalez FJ, Li S, Isoherranen N, Yang D, Ma X, Patterson AD, Xie W. Inhibition of heme-thiolate monooxygenase CYP1B1 prevents hepatic stellate cell activation and liver fibrosis by accumulating trehalose. Sci Transl Med. 2024;16(766):eadk8446. PMCID: PMC12084873.
PubMed PMID: 39321267
Journal: Clin Cancer Res
Publication Date: 2024-07-15
DOI: 10.1158/1078-0432.CCR-24-0423
NIH Citation: Abdullah KG. Classifying glioma via liquid biopsy--progress towards an unmet clinical need. Clin Cancer Res. 2024;.
PubMed PMID: 38652677
Journal: J Clin Oncol
Publication Date: 2024-06-10
DOI: 10.1200/JCO.23.01544
NIH Citation: Appleman LJ, Kim SE, Harris WB, Pal SK, Pins MR, Kolesar J, Agarwal N, Parikh RA, Vaena DA, Ryan CW, Hashmi M, Costello BA, Cella D, Dutcher JP, DiPaola RS, Haas NB, Wagner LI, Carducci MA. Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. J Clin Oncol. 2024;42(17):2061-2070. PMCID: PMC11514296.
PubMed PMID: 38531002
Journal: J Am Chem Soc
Publication Date: 2024-06-05
DOI: 10.1021/jacs.4c04081
NIH Citation: Borgini M, Huang QN, Chen PP, Geib SJ, Houk KN, Wipf P. Rhodium(I)-Catalyzed Annulation of Bicyclo[1.1.0]butyl-Substituted Dihydroquinolines and Dihydropyridines. J Am Chem Soc. 2024;. PMCID: PMC11157536.
PubMed PMID: 38767459
Journal: J Control Release
Publication Date: 2024-06-01
DOI: 10.1016/j.jconrel.2024.04.041
NIH Citation: Chen Y, Chen CY, Huang H, Luo Z, Mu Y, Li S, Li S. Knocking down of Xkr8 enhances chemotherapy efficacy through modulating tumor immune microenvironment. J Control Release. 2024;. PMCID: PMC11186464.
PubMed PMID: 38685385
Journal: Clin Cancer Res
Publication Date: 2024-05-01
DOI: 10.1158/1078-0432.CCR-23-1977
NIH Citation: Mamounas EP, Bandos H, Rastogi P, Zhang Y, Treuner K, Lucas PC, Geyer CE, Fehrenbacher L, Chia SK, Brufsky AM, Walshe JM, Soori GS, Dakhil S, Paik S, Swain SM, Sgroi DC, Schnabel CA, Wolmark N. Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clin Cancer Res. 2024;. PMCID: PMC11061597.
PubMed PMID: 38376912
Journal: J Clin Oncol
Publication Date: 2024-04-20
DOI: 10.1200/JCO.23.01428
NIH Citation: Geyer CE Jr, Blum JL, Yothers G, Asmar L, Flynn PJ, Robert NJ, Hopkins JO, O'Shaughnessy JA, Rastogi P, Puhalla SL, Hilton CJ, Dang CT, Gómez HL, Vukelja SJ, Lyss AP, Paul D, Brufsky AM, Colangelo LH, Swain SM, Mamounas EP, Wolmark N. Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). J Clin Oncol. 2024;:JCO2301428. PMCID: PMC11095853.
PubMed PMID: 38335467
Journal: Cancer Lett
Publication Date: 2024-04-01
DOI: 10.1016/j.canlet.2024.216679
NIH Citation: Butrovich MA, Qin J, Xue X, Ivy SP, Nolin TD, Beumer JH. Impact of the 2021 CKD-EPI equation on anticancer pharmacotherapy in black and non-black cancer patients. Cancer Lett. 2024;:216679. PMCID: PMC10939791.
PubMed PMID: 38307411
Journal: J Clin Oncol
Publication Date: 2024-03-20
DOI: 10.1200/JCO.23.01994
NIH Citation: Rastogi P, O'Shaughnessy J, Martin M, Boyle F, Cortes J, Rugo HS, Goetz MP, Hamilton EP, Huang CS, Senkus E, Tryakin A, Cicin I, Testa L, Neven P, Huober J, Shao Z, Wei R, André V, Munoz M, San Antonio B, Shahir A, Harbeck N, Johnston S. Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Ou J Clin Oncol. 2024;:JCO2301994. PMCID: PMC10950161.
PubMed PMID: 38194616
Journal: J Control Release
Publication Date: 2024-03-10
DOI: 10.1016/j.jconrel.2024.03.011
NIH Citation: Chen Y, Chen CY, Huang H, Luo Z, Mu Y, Li S, Li S. Knocking down of Xkr8 enhances chemotherapy efficacy through modulating tumor immune microenvironment. J Control Release. 2024;.
PubMed PMID: 38471639
Journal: Acta Pharm Sin B
Publication Date: 2024-03-01
DOI: 10.1016/j.apsb.2023.12.006
NIH Citation: Xu P, Xi Y, Kim JW, Zhu J, Zhang M, Xu M, Ren S, Yang D, Ma X, Xie W. Sulfation of chondroitin and bile acids converges to antagonize Wnt/β-catenin signaling and inhibit APC deficiency-induced gut tumorigenesis. Acta Pharm Sin B. 2024;14(3):1241-1256. PMCID: PMC10935170.
PubMed PMID: 38487006
Journal: Nat Commun
Publication Date: 2024-02-20
DOI: 10.1038/s41467-024-45960-2
NIH Citation: Saeed A, Park R, Pathak H, Al-Bzour AN, Dai J, Phadnis M, Al-Rajabi R, Kasi A, Baranda J, Sun W, Williamson S, Chiu YC, Osmanbeyoglu HU, Madan R, Abushukair H, Mulvaney K, Godwin AK, Saeed A. Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nat Commun. 2024;15(1):1533. PMCID: PMC10879200.
PubMed PMID: 38378868
Journal: J Thorac Oncol
Publication Date: 2024-02-01
DOI: 10.1016/j.jtho.2023.11.022
NIH Citation: Owonikoko TK. SCLC Classification by Platinum Sensitivity in the Era of Immunotherapy: Mere Relic or a Valuable Treasure to Keep? J Thorac Oncol. 2024;19(2):193-195.
PubMed PMID: 38325978
Journal: Cancer Discov
Publication Date: 2024-01-12
DOI: 10.1158/2159-8290.CD-23-0964
NIH Citation: Kelly WK, Danila DC, Lin CC, Lee JL, Matsubara N, Ward PJ, Armstrong AJ, Pook D, Kim M, Dorff TB, Fischer S, Lin YC, Horvath LG, Sumey C, Yang Z, Jurida G, Smith KM, Connarn JN, Penny HL, Stieglmaier J, Appleman LJ. Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study. Cancer Discov. 2024;:OF1-OF14. PMCID: PMC10784743.
PubMed PMID: 37861461
Journal: Clin Cancer Res
Publication Date: 2024-01-05
DOI: 10.1158/1078-0432.CCR-23-2630
NIH Citation: Beumer JH, Salamone SJ. Project Confirm: Accelerated Drug Approvals for CML-Letter. Clin Cancer Res. 2024;30(1):235-236. PMCID: PMC10783536.
PubMed PMID: 38178775
Journal: Nat Commun
Publication Date: 2024-01-04
DOI: 10.1038/s41467-023-44572-6
NIH Citation: Luo Z, Huang Y, Batra N, Chen Y, Huang H, Wang Y, Zhang Z, Li S, Chen CY, Wang Z, Sun J, Wang QJ, Yang D, Lu B, Conway JF, Li LY, Yu AM, Li S. Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nat Commun. 2024;15(1):255. PMCID: PMC10766965.
PubMed PMID: 38177179
Journal: J Natl Compr Canc Netw
Publication Date: 2023-12-27
DOI: 10.6004/jnccn.2023.7070
NIH Citation: Murthy P, Zenati MS, AlMasri SS, DeSilva A, Singhi AD, Paniccia A, Lee KK, Simmons RL, Bahary N, Lotze MT, Zureikat AH. Impact of Recombinant Granulocyte Colony-Stimulating Factor During Neoadjuvant Therapy on Outcomes of Resected Pancreatic Cancer. J Natl Compr Canc Netw. 2023;:1-13.
PubMed PMID: 38150819
Journal: EClinicalMedicine
Publication Date: 2023-12-01
DOI: 10.1016/j.eclinm.2023.102317
NIH Citation: Shaverdashvili K, Reyes V, Wang H, Mehta D, Marsh C, Waas JK, VanderWeele RA, Peracha SM, Liang H, Socinski MA, Gerber DE, Dowell JE, Villaruz LC. A phase II clinical trial evaluating the safety and efficacy of durvalumab as first line therapy in advanced and metastatic non-small cell lung cancer patients with Eastern Cooperative Oncology Group performance status of 2. EClinicalMedicine. 2023;66:102317. PMCID: PMC10772260.
PubMed PMID: 38192592
Journal: Cancer Lett
Publication Date: 2023-10-28
DOI: 10.1016/j.canlet.2023.216396
NIH Citation: Luo Z, Eichinger KM, Zhang A, Li S. Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy. Cancer Lett. 2023;:216396. PMCID: PMC10591810.
PubMed PMID: 37739209
Journal: J Am Chem Soc
Publication Date: 2023-08-02
DOI: 10.1021/jacs.3c02752
NIH Citation: Albright S, Cacace M, Tivon Y, Deiters A. Cell Surface Labeling and Detection of Protein Tyrosine Kinase 7 via Covalent Aptamers. J Am Chem Soc. 2023;145(30):16458-16463. PMCID: PMC10401710.
PubMed PMID: 37473438
Journal: J Clin Oncol
Publication Date: 2023-07-10
DOI: 10.1200/JCO.22.02570
NIH Citation: Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE Jr, Wickerham DL, Wolmark N. Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor-Positive Breast Cancer. J Clin Oncol. 2023;41(20):3565-3575.
PubMed PMID: 37406456
Journal: Cell Res
Publication Date: 2023-07-01
DOI: 10.1038/s41422-023-00815-1
NIH Citation: Foldi J, Geyer CE Jr. Precision medicine for metastatic TNBC: the FUTURE is now. Cell Res. 2023;33(7):491-492. PMCID: PMC10313756.
PubMed PMID: 37156878
Journal: J Clin Oncol
Publication Date: 2023-06-01
DOI: 10.1200/JCO.22.02823
NIH Citation: Paz-Ares L, Champiat S, Lai WV, Izumi H, Govindan R, Boyer M, Hummel HD, Borghaei H, Johnson ML, Steeghs N, Blackhall F, Dowlati A, Reguart N, Yoshida T, He K, Gadgeel SM, Felip E, Zhang Y, Pati A, Minocha M, Mukherjee S, Goldrick A, Nagorsen D, Hashemi Sadraei N, Owonikoko TK. Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study. J Clin Oncol. 2023;41(16):2893-2903. PMCID: PMC10414718.
PubMed PMID: 36689692
Journal: Cell Rep Med
Publication Date: 2023-02-21
DOI: 10.1016/j.xcrm.2023.100916
NIH Citation: Saeed A, Park R, Dai J, Al-Rajabi R, Kasi A, Baranda J, Williamson S, Saeed A, Ripp J, Collins Z, Mulvaney K, Shugrue M, Firth-Braun J, Godwin AK, Madan R, Phadnis M, Sun W. Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results. Cell Rep Med. 2023;4(2):100916. PMCID: PMC9975105.
PubMed PMID: 36702123
Journal: Clin Cancer Res
Publication Date: 2023-02-16
DOI: 10.1158/1078-0432.CCR-22-1768
NIH Citation: Mascarella MA, Olonisakin TF, Rumde P, Vendra V, Nance MA, Kim S, Kubik MW, Sridharan SS, Ferris RL, Fenton MJ, Clayburgh DR, Ohr JP, Joyce SC, Sen M, Herman JG, Grandis JR, Zandberg DP, Duvvuri U. Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit. Clin Cancer Res. 2023;29(4):723-730. PMCID: PMC11232033.
PubMed PMID: 36595540
Journal: Theranostics
Publication Date: 2023-01-01
DOI: 10.7150/thno.76614
NIH Citation: Zhang Y, Li J, Huang Y, Chen Y, Luo Z, Huang H, West RE 3rd, Nolin TD, Wang Z, Li S. Improved antitumor activity against prostate cancer via synergistic targeting of Myc and GFAT-1. Theranostics. 2023;13(2):578-595. PMCID: PMC9830436.
PubMed PMID: 36632215
Journal: JAMA Surg
Publication Date: 2023-01-01
DOI: 10.1001/jamasurg.2022.5696
NIH Citation: Hammad AY, Hodges JC, AlMasri S, Paniccia A, Lee KK, Bahary N, Singhi AD, Ellsworth SG, Aldakkak M, Evans DB, Tsai S, Zureikat A. Evaluation of Adjuvant Chemotherapy Survival Outcomes Among Patients With Surgically Resected Pancreatic Carcinoma With Node-Negative Disease After Neoadjuvant Therapy. JAMA Surg. 2023;158(1):55-62. PMCID: PMC9685551.
PubMed PMID: 36416848
Journal: JAMA Oncol
Publication Date: 2022-12-01
DOI: 10.1001/jamaoncol.2022.4452
NIH Citation: Beumer JH, Chu E, Salamone SJ. All Optimal Dosing Roads Lead to Therapeutic Drug Monitoring-Why Take the Slow Lane. JAMA Oncol. 2022;8(12):1733-1735. PMCID: PMC9772116.
PubMed PMID: 36264552
Journal: Nat Rev Clin Oncol
Publication Date: 2022-12-01
DOI: 10.1038/s41571-022-00684-4
NIH Citation: Carleton N, McAuliffe PF. Are the chronological age cutoffs used in clinical oncology guidelines biologically meaningful? Nat Rev Clin Oncol. 2022;19(12):745-746. PMCID: PMC9675711.
PubMed PMID: 36042383
Journal: Acta Pharm Sin B
Publication Date: 2022-03-01
DOI: 10.1016/j.apsb.2021.09.024
NIH Citation: Moharil P, Wan Z, Pardeshi A, Li J, Huang H, Luo Z, Rathod S, Zhang Z, Chen Y, Zhang B, Fernandez CA, Sun J, Li S. Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages. Acta Pharm Sin B. 2022;12(3):1148-1162. PMCID: PMC9072252.
PubMed PMID: 35530140
Journal: Lancet Oncol
Publication Date: 2022-03-01
DOI: 10.1016/S1470-2045(22)00086-9
NIH Citation: Diamantopoulos LN, Appleman LJ. HLA-A*03 and response to immune checkpoint blockade in patients with cancer. Lancet Oncol. 2022;23(3):e99.
PubMed PMID: 35240100
Journal: Sci Adv
Publication Date: 2021-12-10
DOI: 10.1126/sciadv.abj4226
NIH Citation: Wan Z, Sun R, Liu YW, Li S, Sun J, Li J, Zhu J, Moharil P, Zhang B, Ren P, Ren G, Zhang M, Ma X, Dai S, Yang D, Lu B, Li S. Targeting metabotropic glutamate receptor 4 for cancer immunotherapy. Sci Adv. 2021;7(50):eabj4226. PMCID: PMC8664261.
PubMed PMID: 34890233
Journal: Chem Soc Rev
Publication Date: 2021-11-29
DOI: 10.1039/d1cs00257k
NIH Citation: Darrah KE, Deiters A. Translational control of gene function through optically regulated nucleic acids. Chem Soc Rev. 2021;50(23):13253-13267. PMCID: PMC8900068.
PubMed PMID: 34739027
Journal: Clin Cancer Res
Publication Date: 2021-11-15
DOI: 10.1158/1078-0432.CCR-20-4789
NIH Citation: Vyas A, Harbison RA, Faden DL, Kubik M, Palmer D, Zhang Q, Osmanbeyoglu HU, Kiselyov K, Méndez E, Duvvuri U. Recurrent Human Papillomavirus-Related Head and Neck Cancer Undergoes Metabolic Reprogramming and Is Driven by Oxidative Phosphorylation. Clin Cancer Res. 2021;27(22):6250-6264. PMCID: PMC8611487.
PubMed PMID: 34407971
Journal: J Am Chem Soc
Publication Date: 2021-11-10
DOI: 10.1021/jacs.1c08723
NIH Citation: Darrah K, Wesalo J, Lukasak B, Tsang M, Chen JK, Deiters A. Small Molecule Control of Morpholino Antisense Oligonucleotide Function through Staudinger Reduction. J Am Chem Soc. 2021;143(44):18665-18671. PMCID: PMC9014490.
PubMed PMID: 34705461
Journal: EBioMedicine
Publication Date: 2021-08-01
DOI: 10.1016/j.ebiom.2021.103489
NIH Citation: Gomez Marti JL, Nasrazadani A, Brufsky AM. Ovarian function suppression as a potential mechanism of chemotherapy. EBioMedicine. 2021;70:103489. PMCID: PMC8318981.
PubMed PMID: 34280778
Journal: J Clin Oncol
Publication Date: 2021-07-20
DOI: 10.1200/JCO.20.02824
NIH Citation: Cobleigh MA, Anderson SJ, Siziopikou KP, Arthur DW, Rabinovitch R, Julian TB, Parda DS, Seaward SA, Carter DL, Lyons JA, Dillmon MS, Magrinat GC, Kavadi VS, Zibelli AM, Tiriveedhi L, Hill ML, Melnik MK, Beriwal S, Mamounas EP, Wolmark N. Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial. J Clin Oncol. 2021;39(21):2367-2374. PMCID: PMC8462554.
PubMed PMID: 33739848
Journal: Gastroenterology
Publication Date: 2021-07-01
DOI: 10.1053/j.gastro.2021.03.048
NIH Citation: Xu P, Xi Y, Zhu J, Zhang M, Luka Z, Stolz DB, Cai X, Xie Y, Xu M, Ren S, Huang Z, Yang D, York JD, Ma X, Xie W. Intestinal Sulfation Is Essential to Protect Against Colitis and Colonic Carcinogenesis. Gastroenterology. 2021;161(1):271-286.e11. PMCID: PMC8238844.
PubMed PMID: 33819483
Journal: Leukemia
Publication Date: 2021-07-01
DOI: 10.1038/s41375-020-01047-7
NIH Citation: Namburi S, Broxmeyer HE, Hong CS, Whiteside TL, Boyiadzis M. DPP4(+) exosomes in AML patients' plasma suppress proliferation of hematopoietic progenitor cells. Leukemia. 2021;35(7):1925-1932. PMCID: PMC10165724.
PubMed PMID: 33139859
Journal: J Immunother Cancer
Publication Date: 2021-07-01
DOI: 10.1136/jitc-2021-003299
NIH Citation: Colen RR, Rolfo C, Ak M, Ayoub M, Ahmed S, Elshafeey N, Mamindla P, Zinn PO, Ng C, Vikram R, Bakas S, Peterson CB, Rodon Ahnert J, Subbiah V, Karp DD, Stephen B, Hajjar J, Naing A. Author response to Cunha et al. J Immunother Cancer. 2021;9(7). PMCID: PMC8317086.
PubMed PMID: 34315823
Journal: J Am Chem Soc
Publication Date: 2021-06-23
DOI: 10.1021/jacs.1c04324
NIH Citation: Ryan A, Liu J, Deiters A. Targeted Protein Degradation through Fast Optogenetic Activation and Its Application to the Control of Cell Signaling. J Am Chem Soc. 2021;143(24):9222-9229.
PubMed PMID: 34121391
Journal: J Thorac Oncol
Publication Date: 2021-06-01
DOI: 10.1016/j.jtho.2021.02.010
NIH Citation: Camidge DR, Otterson GA, Clark JW, Ignatius Ou SH, Weiss J, Ades S, Shapiro GI, Socinski MA, Murphy DA, Conte U, Tang Y, Wang SC, Wilner KD, Villaruz LC. Crizotinib in Patients With MET-Amplified NSCLC. J Thorac Oncol. 2021;16(6):1017-1029.
PubMed PMID: 33676017
Journal: J Clin Oncol
Publication Date: 2021-05-01
DOI: 10.1200/JCO.20.03477
NIH Citation: Johnston SRD, Harbeck N, Toi M, Martin M, O'Shaughnessy J, Rastogi P. Reply to K. Hashimoto and A. Shimomura. J Clin Oncol. 2021;39(13):1507-1508.
PubMed PMID: 33630658
Journal: Nat Rev Gastroenterol Hepatol
Publication Date: 2021-04-01
DOI: 10.1038/s41575-020-00386-1
NIH Citation: Gough A, Soto-Gutierrez A, Vernetti L, Ebrahimkhani MR, Stern AM, Taylor DL. Human biomimetic liver microphysiology systems in drug development and precision medicine. Nat Rev Gastroenterol Hepatol. 2021;18(4):252-268. PMCID: PMC9106093.
PubMed PMID: 33335282
Journal: Leukemia
Publication Date: 2021-04-01
DOI: 10.1038/s41375-020-01017-z
NIH Citation: Lontos K, Yabes JG, Farah RJ, Boyiadzis M. Impact of upfront chemotherapy on overall survival in isolated myeloid sarcoma. Leukemia. 2021;35(4):1193-1196.
PubMed PMID: 32814841
Journal: J Immunother Cancer
Publication Date: 2021-04-01
DOI: 10.1136/jitc-2020-001752
NIH Citation: Colen RR, Rolfo C, Ak M, Ayoub M, Ahmed S, Elshafeey N, Mamindla P, Zinn PO, Ng C, Vikram R, Bakas S, Peterson CB, Rodon Ahnert J, Subbiah V, Karp DD, Stephen B, Hajjar J, Naing A. Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers. J Immunother Cancer. 2021;9(4). PMCID: PMC8051405.
PubMed PMID: 33849924
Journal: Biomaterials
Publication Date: 2021-03-01
DOI: 10.1016/j.biomaterials.2021.120708
NIH Citation: Huang H, Huang Y, Chen Y, Luo Z, Zhang Z, Sun R, Wan Z, Sun J, Lu B, Zhang L, Hu J, Li S. A novel immunochemotherapy based on targeting of cyclooxygenase and induction of immunogenic cell death. Biomaterials. 2021;270:120708. PMCID: PMC7910750.
PubMed PMID: 33578254
Journal: Biomaterials
Publication Date: 2021-02-01
DOI: 10.1016/j.biomaterials.2020.120629
NIH Citation: Sun J, Wan Z, Xu J, Luo Z, Ren P, Zhang B, Diao D, Huang Y, Li S. Tumor size-dependent abscopal effect of polydopamine-coated all-in-one nanoparticles for immunochemo-photothermal therapy of early- and late-stage metastatic cancer. Biomaterials. 2021;269:120629. PMCID: PMC8466812.
PubMed PMID: 33387938
Journal: J Clin Oncol
Publication Date: 2021-01-20
DOI: 10.1200/JCO.20.02963
NIH Citation: Saura C, Oliveira M, Kim SB, Yau T, Takano T, Brufsky A. Reply to T. J. A. Dekker, D.-C. Mo et al, and A. Seidman et al. J Clin Oncol. 2021;39(3):254-255.
PubMed PMID: 33332192
Journal: Cancer Res
Publication Date: 2020-10-15
DOI: 10.1158/0008-5472.CAN-20-1031
NIH Citation: Fang Z, Wang Y, Wang Z, Xu M, Ren S, Yang D, Hong M, Xie W. ERINA Is an Estrogen-Responsive LncRNA That Drives Breast Cancer through the E2F1/RB1 Pathway. Cancer Res. 2020;80(20):4399-4413. PMCID: PMC7572695.
PubMed PMID: 32826278
Journal: J Immunother Cancer
Publication Date: 2020-10-01
DOI: 10.1136/jitc-2020-000810
NIH Citation: Boyiadzis MM, Aksentijevich I, Arber DA, Barrett J, Brentjens RJ, Brufsky J, Cortes J, De Lima M, Forman SJ, Fuchs EJ, Fukas LJ, Gore SD, Litzow MR, Miller JS, Pagel JM, Waller EK, Tallman MS. The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia. J Immunother Cancer. 2020;8(2). PMCID: PMC7574947.
PubMed PMID: 33077513
Journal: Clin Cancer Res
Publication Date: 2020-08-15
DOI: 10.1158/1078-0432.CCR-20-0152
NIH Citation: Swain SM, Tang G, Brauer HA, Goerlitz DS, Lucas PC, Robidoux A, Harris BT, Bandos H, Ren Y, Geyer CE Jr, Rastogi P, Mamounas EP, Wolmark N. NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response. Clin Cancer Res. 2020;26(16):4233-4241. PMCID: PMC7724952.
PubMed PMID: 32371537
Journal: Drugs
Publication Date: 2020-06-01
DOI: 10.1007/s40265-020-01320-0
NIH Citation: Somasundaram A, Socinski MA, Villaruz LC. Immune Checkpoint Blockade in Oncogene-Driven Non-Small-Cell Lung Cancer. Drugs. 2020;80(9):883-892. PMCID: PMC8579493.
PubMed PMID: 32436070
Journal: Lancet Oncol
Publication Date: 2020-03-01
DOI: 10.1016/S1470-2045(19)30857-5
NIH Citation: Nasrazadani A, Brufsky AM. Capivasertib inhibits a key pathway in metastatic breast cancer. Lancet Oncol. 2020;21(3):318-319.
PubMed PMID: 32035019
Journal: J Clin Oncol
Publication Date: 2020-02-10
DOI: 10.1200/JCO.19.01455
NIH Citation: Fehrenbacher L, Cecchini RS, Geyer CE Jr, Rastogi P, Costantino JP, Atkins JN, Crown JP, Polikoff J, Boileau JF, Provencher L, Stokoe C, Moore TD, Robidoux A, Flynn PJ, Borges VF, Albain KS, Swain SM, Paik S, Mamounas EP, Wolmark N. NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2. J Clin Oncol. 2020;38(5):444-453. PMCID: PMC7007289.
PubMed PMID: 31821109
Journal: J Am Chem Soc
Publication Date: 2020-02-05
DOI: 10.1021/jacs.9b12718
NIH Citation: Naro Y, Darrah K, Deiters A. Optical Control of Small Molecule-Induced Protein Degradation. J Am Chem Soc. 2020;142(5):2193-2197. PMCID: PMC7229639.
PubMed PMID: 31927988
Journal: Theranostics
Publication Date: 2020-01-20
DOI: 10.7150/thno.38973
NIH Citation: Ma W, Sun J, Xu J, Luo Z, Diao D, Zhang Z, Oberly PJ, Minnigh MB, Xie W, Poloyac SM, Huang Y, Li S. Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier. Theranostics. 2020;10(6):2463-2478. PMCID: PMC7052901.
PubMed PMID: 32194813
Journal: Acta Pharm Sin B
Publication Date: 2020-01-01
DOI: 10.1016/j.apsb.2019.09.011
NIH Citation: Wang Y, Fang Z, Hong M, Yang D, Xie W. Long-noncoding RNAs (lncRNAs) in drug metabolism and disposition, implications in cancer chemo-resistance. Acta Pharm Sin B. 2020;10(1):105-112. PMCID: PMC6976993.
PubMed PMID: 31993309
Journal: Theranostics
Publication Date: 2020-01-01
DOI: 10.7150/thno.38287
NIH Citation: Sun J, Chen Y, Xu J, Song X, Wan Z, Du Y, Ma W, Li X, Zhang L, Li S. High Loading of Hydrophobic and Hydrophilic Agents via Small Immunostimulatory Carrier for Enhanced Tumor Penetration and Combinational Therapy. Theranostics. 2020;10(3):1136-1150. PMCID: PMC6956803.
PubMed PMID: 31938056
Journal: Acta Pharm Sin B
Publication Date: 2020-01-01
DOI: 10.1016/j.apsb.2019.12.016
NIH Citation: Xie W. Editorial of Special Issue on Drug Metabolism and Disposition in Diseases. Acta Pharm Sin B. 2020;10(1):2. PMCID: PMC6977160.
PubMed PMID: 31993303
Journal: Lancet
Publication Date: 2019-12-14
DOI: 10.1016/S0140-6736(19)32514-0
NIH Citation: Vicini FA, Cecchini RS, White JR, Arthur DW, Julian TB, Rabinovitch RA, Kuske RR, Ganz PA, Parda DS, Scheier MF, Winter KA, Paik S, Kuerer HM, Vallow LA, Pierce LJ, Mamounas EP, McCormick B, Costantino JP, Bear HD, Germain I, Gustafson G, Grossheim L, Petersen IA, Hudes RS, Curran WJ Jr, Bryant JL, Wolmark N. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. Lancet. 2019;394(10215):2155-2164. PMCID: PMC7199428.
PubMed PMID: 31813636
Journal: Clin Cancer Res
Publication Date: 2019-10-01
DOI: 10.1158/1078-0432.CCR-18-3453
NIH Citation: Duvvuri U, George J, Kim S, Alvarado D, Neumeister VM, Chenna A, Gedrich R, Hawthorne T, LaVallee T, Grandis JR, Bauman JE. Molecular and Clinical Activity of CDX-3379, an Anti-ErbB3 Monoclonal Antibody, in Head and Neck Squamous Cell Carcinoma Patients. Clin Cancer Res. 2019;25(19):5752-5758. PMCID: PMC6820348.
PubMed PMID: 31308059
Journal: Lancet Oncol
Publication Date: 2019-10-01
DOI: 10.1016/S1470-2045(19)30507-8
NIH Citation: Nasrazadani A, Brufsky AM. CDK4/6 inhibitors: taking the place of chemotherapy? Lancet Oncol. 2019;20(10):1329-1330.
PubMed PMID: 31494036
Journal: Nat Commun
Publication Date: 2019-09-26
DOI: 10.1038/s41467-019-12260-z
NIH Citation: Courtney TM, Deiters A. Optical control of protein phosphatase function. Nat Commun. 2019;10(1):4384. PMCID: PMC6763421.
PubMed PMID: 31558717
Journal: Gastroenterology
Publication Date: 2019-09-01
DOI: 10.1053/j.gastro.2019.05.066
NIH Citation: Yan J, Tung HC, Li S, Niu Y, Garbacz WG, Lu P, Bi Y, Li Y, He J, Xu M, Ren S, Monga SP, Schwabe RF, Yang D, Xie W. Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice. Gastroenterology. 2019;157(3):793-806.e14. PMCID: PMC6707837.
PubMed PMID: 31170413
Journal: Hepatology
Publication Date: 2019-09-01
DOI: 10.1002/hep.30691
NIH Citation: Xie Y, Xu M, Deng M, Li Z, Wang P, Ren S, Guo Y, Ma X, Fan J, Billiar TR, Xie W. Activation of Pregnane X Receptor Sensitizes Mice to Hemorrhagic Shock-Induced Liver Injury. Hepatology. 2019;70(3):995-1010. PMCID: PMC6717545.
PubMed PMID: 31038762
Journal: EBioMedicine
Publication Date: 2019-08-01
DOI: 10.1016/j.ebiom.2019.07.073
NIH Citation: Nasrazadani A, Brufsky AM. Artificial intelligence-directed prognostication of breast cancer. EBioMedicine. 2019;46:6-7. PMCID: PMC6712046.
PubMed PMID: 31378696
Journal: Nat Commun
Publication Date: 2019-07-18
DOI: 10.1038/s41467-019-11007-0
NIH Citation: Elshafeey N, Kotrotsou A, Hassan A, Elshafei N, Hassan I, Ahmed S, Abrol S, Agarwal A, El Salek K, Bergamaschi S, Acharya J, Moron FE, Law M, Fuller GN, Huse JT, Zinn PO, Colen RR. Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma. Nat Commun. 2019;10(1):3170. PMCID: PMC6639324.
PubMed PMID: 31320621
Journal: Biomaterials
Publication Date: 2019-07-01
DOI: 10.1016/j.biomaterials.2019.04.025
NIH Citation: Xu J, Sun J, Ho PY, Luo Z, Ma W, Zhao W, Rathod SB, Fernandez CA, Venkataramanan R, Xie W, Yu AM, Li S. Creatine based polymer for codelivery of bioengineered MicroRNA and chemodrugs against breast cancer lung metastasis. Biomaterials. 2019;210:25-40. PMCID: PMC6538300.
PubMed PMID: 31054369
Journal: Gastroenterology
Publication Date: 2019-06-01
DOI: 10.1053/j.gastro.2019.02.037
NIH Citation: Singhi AD, George B, Greenbowe JR, Chung J, Suh J, Maitra A, Klempner SJ, Hendifar A, Milind JM, Golan T, Brand RE, Zureikat AH, Roy S, Schrock AB, Miller VA, Ross JS, Ali SM, Bahary N. Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers. Gastroenterology. 2019;156(8):2242-2253.e4.
PubMed PMID: 30836094
Journal: Clin Cancer Res
Publication Date: 2019-03-01
DOI: 10.1158/1078-0432.CCR-18-3078
NIH Citation: Clump DA, Pickering CR, Skinner HD. Predicting Outcome in Head and Neck Cancer: miRNAs with Potentially Big Effects. Clin Cancer Res. 2019;25(5):1441-1442. PMCID: PMC6415532.
PubMed PMID: 30413524
Journal: J Immunother Cancer
Publication Date: 2018-12-04
DOI: 10.1186/s40425-018-0460-5
NIH Citation: Boyiadzis MM, Dhodapkar MV, Brentjens RJ, Kochenderfer JN, Neelapu SS, Maus MV, Porter DL, Maloney DG, Grupp SA, Mackall CL, June CH, Bishop MR. Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance. J Immunother Cancer. 2018;6(1):137. PMCID: PMC6278156.
PubMed PMID: 30514386
Journal: Nat Med
Publication Date: 2018-12-01
DOI: 10.1038/s41591-018-0273-6
NIH Citation: Guo GL, Xie W. Metformin action through the microbiome and bile acids. Nat Med. 2018;24(12):1789-1790.
PubMed PMID: 30523325
Journal: J Control Release
Publication Date: 2018-10-28
DOI: 10.1016/j.jconrel.2018.09.011
NIH Citation: Xu J, Zhao W, Sun J, Huang Y, Wang P, Venkataramanan R, Yang D, Ma X, Rana A, Li S. Novel glucosylceramide synthase inhibitor based prodrug copolymer micelles for delivery of anticancer agents. J Control Release. 2018;288:212-226. PMCID: PMC6177216.
PubMed PMID: 30223045
